全文获取类型
| 收费全文 | 8948篇 |
| 免费 | 715篇 |
| 国内免费 | 16篇 |
专业分类
| 耳鼻咽喉 | 37篇 |
| 儿科学 | 255篇 |
| 妇产科学 | 151篇 |
| 基础医学 | 1132篇 |
| 口腔科学 | 142篇 |
| 临床医学 | 1178篇 |
| 内科学 | 1826篇 |
| 皮肤病学 | 93篇 |
| 神经病学 | 713篇 |
| 特种医学 | 418篇 |
| 外科学 | 1581篇 |
| 综合类 | 246篇 |
| 一般理论 | 8篇 |
| 预防医学 | 836篇 |
| 眼科学 | 80篇 |
| 药学 | 503篇 |
| 中国医学 | 13篇 |
| 肿瘤学 | 467篇 |
出版年
| 2021年 | 156篇 |
| 2020年 | 100篇 |
| 2019年 | 168篇 |
| 2018年 | 203篇 |
| 2017年 | 128篇 |
| 2016年 | 152篇 |
| 2015年 | 156篇 |
| 2014年 | 177篇 |
| 2013年 | 345篇 |
| 2012年 | 489篇 |
| 2011年 | 499篇 |
| 2010年 | 291篇 |
| 2009年 | 232篇 |
| 2008年 | 427篇 |
| 2007年 | 464篇 |
| 2006年 | 477篇 |
| 2005年 | 392篇 |
| 2004年 | 446篇 |
| 2003年 | 390篇 |
| 2002年 | 363篇 |
| 2001年 | 271篇 |
| 2000年 | 267篇 |
| 1999年 | 249篇 |
| 1998年 | 118篇 |
| 1997年 | 101篇 |
| 1996年 | 90篇 |
| 1995年 | 67篇 |
| 1994年 | 72篇 |
| 1993年 | 71篇 |
| 1992年 | 187篇 |
| 1991年 | 195篇 |
| 1990年 | 177篇 |
| 1989年 | 164篇 |
| 1988年 | 119篇 |
| 1987年 | 135篇 |
| 1986年 | 120篇 |
| 1985年 | 133篇 |
| 1984年 | 100篇 |
| 1983年 | 90篇 |
| 1982年 | 61篇 |
| 1981年 | 51篇 |
| 1980年 | 50篇 |
| 1979年 | 72篇 |
| 1978年 | 63篇 |
| 1977年 | 44篇 |
| 1976年 | 42篇 |
| 1974年 | 46篇 |
| 1973年 | 44篇 |
| 1972年 | 38篇 |
| 1969年 | 39篇 |
排序方式： 共有9679条查询结果，搜索用时 31 毫秒
1.
Robert C. Lynall J. Troy Blackburn Kevin M. Guskiewicz Stephen W. Marshall Prudence Plummer Jason P. Mihalik 《Journal of Science and Medicine in Sport》2019,22(5):503-508
Objectives
Despite evidence for increased musculoskeletal injury after concussion recovery, there is a lack of dynamic balance assessments that could inform management and research into this increased injury risk post-concussion. Our purpose was to identify tandem gait dynamic balance deficits in recreational athletes with a concussion history within the past 18-months compared to matched controls.Design
Cross-sectional, laboratory study.Methods
Fifteen participants with a concussion history (age: 19.7 ± 0.9 years; 9 females; median time since concussion 126 days, range 28–432 days), and 15 matched controls (19.7 ± 1.6 years; 9 females) with no recent concussion history participated. We measured center-of-pressure (COP) outcomes (velocity, path length, speed, dual-task cost) under 4 tandem gait conditions: (1) tandem gait, (2) tandem gait, eyes closed, (3) tandem gait, eyes open, cognitive distraction, and (4) tandem gait, eyes closed, cognitive distraction.Results
The concussion history group demonstrated slower tandem gait velocity compared to the control group (4.0 cm/s difference), thus velocity was used as a covariate when analyzing COP path length and speed. The concussion history group (23.5%) demonstrated greater COP speed dual-task cost than the control group (16.3%) during the eyes closed dual-task condition. No other comparisons were statistically significant.Conclusions
There may be subtle dynamic balance differences during tandem gait that are detectable after return-to-activity following concussion, but the clinical significance of these findings is unclear. Longitudinal investigations should identify acute movement deficits in varying visual and cognitive scenarios after concussion in comparison with recovery on traditional concussion assessment tools while also recording musculoskeletal injury outcomes. 相似文献2.
3.
4.
Martina A. Steurer Jean Costello Rebecca J. Baer Scott P. Oltman Sky K. Feuer Tania Pacheco-Werner Elizabeth Rogers Marta M. Jankowska Jessica Block Molly McCarthy Matthew S. Pantell Christina Chambers Kelli K. Ryckman Laura L. Jelliffe-Pawlowski 《Paediatric and perinatal epidemiology》2020,34(2):130-138
5.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献6.
7.
8.
9.
10.